HIGHLIGHTS
- who: Phenothiazine- Trifluoperazine- Colon cancer- et al. from the (UNIVERSITY) have published the research work: Process: Submission:05/12/2022 Acceptance:08/07/2022, in the Journal: (JOURNAL)
- what: The aim of this study was to investigate the effects of CaM antagonist PTZ and TFP on cell proliferation and of cells and its impact on protein expression. The authors propose a signalling mechanism in which CaM antagonists suppress CaM-induced PCNA and CD1 activation via POPDC1 in colon cancer, thus inhibiting colon cancer cells proliferation and migration .
- how: These results indicated that PTZ . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.